Macrolides as Immunomodulatory Agents: Progress in Inflammation Research, cartea 92
Editat de Bruce K. Rubin, Masaharu Shinkaien Limba Engleză Hardback – 5 ian 2024
This book summarizes our current knowledge regarding proposed mechanisms for these properties, established clinical results, and what the future may hold with emphasis on novel clinical applications and the fascinating development of non-antimicrobial macrolides with preserved and enhanced immunomodulatory properties.
Din seria Progress in Inflammation Research
- 5%
Preț: 1582.27 lei - 5%
Preț: 1404.03 lei - 5%
Preț: 708.44 lei - 18%
Preț: 930.96 lei - 15%
Preț: 635.31 lei - 5%
Preț: 1274.34 lei - 5%
Preț: 1081.59 lei - 5%
Preț: 700.90 lei - 5%
Preț: 1076.37 lei - 5%
Preț: 644.63 lei - 5%
Preț: 703.43 lei - 5%
Preț: 996.71 lei - 5%
Preț: 1385.03 lei - 5%
Preț: 1080.12 lei - 5%
Preț: 1080.47 lei - 5%
Preț: 991.70 lei - 5%
Preț: 1093.24 lei - 5%
Preț: 705.74 lei - 5%
Preț: 1579.06 lei - 5%
Preț: 641.03 lei - 5%
Preț: 1385.95 lei - 5%
Preț: 639.61 lei - 5%
Preț: 1077.64 lei - 5%
Preț: 1818.92 lei - 15%
Preț: 631.92 lei - 5%
Preț: 1086.24 lei - 5%
Preț: 645.16 lei - 5%
Preț: 1086.05 lei - 24%
Preț: 801.38 lei - 5%
Preț: 700.73 lei - 5%
Preț: 1770.39 lei - 5%
Preț: 706.82 lei - 5%
Preț: 991.70 lei - 5%
Preț: 706.10 lei - 5%
Preț: 1077.79 lei - 15%
Preț: 566.19 lei - 5%
Preț: 639.61 lei - 5%
Preț: 640.15 lei - 5%
Preț: 637.12 lei - 5%
Preț: 1094.10 lei - 5%
Preț: 1074.75 lei - 5%
Preț: 1383.96 lei - 5%
Preț: 1391.67 lei - 5%
Preț: 707.16 lei - 5%
Preț: 1079.77 lei - 5%
Preț: 1076.92 lei
Preț: 1061.93 lei
Preț vechi: 1117.82 lei
-5% Nou
Puncte Express: 1593
Preț estimativ în valută:
203.23€ • 211.11$ • 168.81£
203.23€ • 211.11$ • 168.81£
Carte disponibilă
Livrare economică 08-14 ianuarie 25
Livrare express 27 decembrie 24 - 02 ianuarie 25 pentru 100.85 lei
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783031428586
ISBN-10: 3031428587
Pagini: 287
Ilustrații: VIII, 287 p. 18 illus., 10 illus. in color.
Dimensiuni: 155 x 235 mm
Greutate: 0.67 kg
Ediția:1st ed. 2024
Editura: Springer International Publishing
Colecția Springer
Seria Progress in Inflammation Research
Locul publicării:Cham, Switzerland
ISBN-10: 3031428587
Pagini: 287
Ilustrații: VIII, 287 p. 18 illus., 10 illus. in color.
Dimensiuni: 155 x 235 mm
Greutate: 0.67 kg
Ediția:1st ed. 2024
Editura: Springer International Publishing
Colecția Springer
Seria Progress in Inflammation Research
Locul publicării:Cham, Switzerland
Cuprins
Part I. Mechanisms of Action and Novel Macrolides.- Macrolides and Diseases Associated with Loss of Epithelial Barrier Integrity.- Macrolides and Inflammatory Cells, Signaling, and Mediators.- Part II. Clinical Use for Airway Disease.- Macrolides as Immunomodulatory Agents.- Macrolides and Cystic Fibrosis.- Non-CF Bronchiectasis.- Macrolide Use in Chronic Obstructive Pulmonary Disease.- Macrolides and Asthma Therapy.- Macrolides and Interstitial Lung Diseases.- Macrolides in Acute Respiratory Distress Syndrome and Acute Lung Injury.- Azithromycin for Other Lung Diseases: Lung Transplantation and Sarcoidosis.- Macrolides for Rhinosinusitis and Nasal Polyps.- Part III. Clinical Use for Other Diseases.- Macrolides for Cancer.- Macrolides in Chronic Skin Disorders.- Macrolide Use in Preschool Aged Children with Acute or Recurrent Respiratory Tract Illnesses with Wheezing.- Macrolides and Immunomodulation: Today and the Future.
Notă biografică
Professor Bruce K. Rubin is the Jessie Ball duPont Distinguished Professor of Pediatrics and Biomedical Engineering at Virginia Commonwealth University. He trained in Biomedical Engineering at Oxford University on a Rhodes Scholarship and in Paediatric Respirology in Toronto. He holds the MD and MEngr degrees from Tulane and an MBA degree from Wake Forest University.
Prof. Rubin received the Forest Bird Lifetime Scientific Achievement Award and the Jimmy A Young Medal from the American Association for Respiratory Care, and he is a Prix Galien Laurate. He holds appointments in four medical schools, is on the editorial board of 10 journals, has published more than 300 original research papers and chapters (H-index 74) and holds 10 patents. His research focus is regulation of mucus clearance in health and disease, airway inflammation and immunomodulation, and aerosol delivery of medications.
Dr. Rubin is also a magician, a member of the International Brotherhood of Magicians (Wizard Award) and over the past 30 years has taught medical magic in 43 countries on 5 continents.
Dr. Masaharu Shinkai is the Vice Director of Tokyo Shinagawa Hospital and also the Director of the Clinical Trial Development & Research Center. He holds the MD from National Defense Medical College and a PhD degree from Yokohama City University. He has been involved in many respiratory clinical trials and drug development in Japan. In the last five years, he has been the principal investigator in 35 clinical trials, 22 of which have achieved FPI (First Patient In). He has about 100 articles on PubMed. Most recently, he has published 24 clinical and immunological papers on COVID-19 and its vaccines. His research focus is homeostasis, immunomodulation and mucus regulation in airway inflammation.
Prof. Rubin received the Forest Bird Lifetime Scientific Achievement Award and the Jimmy A Young Medal from the American Association for Respiratory Care, and he is a Prix Galien Laurate. He holds appointments in four medical schools, is on the editorial board of 10 journals, has published more than 300 original research papers and chapters (H-index 74) and holds 10 patents. His research focus is regulation of mucus clearance in health and disease, airway inflammation and immunomodulation, and aerosol delivery of medications.
Dr. Rubin is also a magician, a member of the International Brotherhood of Magicians (Wizard Award) and over the past 30 years has taught medical magic in 43 countries on 5 continents.
Dr. Masaharu Shinkai is the Vice Director of Tokyo Shinagawa Hospital and also the Director of the Clinical Trial Development & Research Center. He holds the MD from National Defense Medical College and a PhD degree from Yokohama City University. He has been involved in many respiratory clinical trials and drug development in Japan. In the last five years, he has been the principal investigator in 35 clinical trials, 22 of which have achieved FPI (First Patient In). He has about 100 articles on PubMed. Most recently, he has published 24 clinical and immunological papers on COVID-19 and its vaccines. His research focus is homeostasis, immunomodulation and mucus regulation in airway inflammation.
Textul de pe ultima copertă
For over 50 years, clinicians have known that macrolide antibiotics have effects on inflammation and the immune system that are not related to their antimicrobial properties. These immunomodulatory properties, best described for treating inflammatory airway diseases, protect the lung and the host and improve clinical status.
This book summarizes our current knowledge regarding proposed mechanisms for these properties, established clinical results, and what the future may hold with emphasis on novel clinical applications and the fascinating development of non-antimicrobial macrolides with preserved and enhanced immunomodulatory properties.
Caracteristici
Uniquely summarizes current knowledge about the non-antimicrobial properties of the macrolide antibiotics Provides latest insight into their current use in treating inflammatory airway diseases Discusses potential use in treating other, non-pulmonary diseases